These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 28027109

  • 1. The Relationship Between Early Haloperidol Response and Associated Extrapyramidal Side Effects.
    Rasmussen SA, Rosebush PI, Mazurek MF.
    J Clin Psychopharmacol; 2017 Feb; 37(1):8-12. PubMed ID: 28027109
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine.
    Rasmussen SA, Rosebush PI, Anglin RE, Mazurek MF.
    Psychiatry Res; 2016 Jul 30; 241():72-7. PubMed ID: 27156027
    [Abstract] [Full Text] [Related]

  • 3. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.
    Maat A, Fouwels A, de Haan L.
    Psychopharmacol Bull; 2008 Jul 30; 41(3):5-10. PubMed ID: 18779773
    [Abstract] [Full Text] [Related]

  • 4. Extrapyramidal side effects and tolerability of risperidone: a review.
    Owens DG.
    J Clin Psychiatry; 1994 May 30; 55 Suppl():29-35. PubMed ID: 7520906
    [Abstract] [Full Text] [Related]

  • 5. Neuromotor dysfunction in early psychosis.
    Whitehorn D, Kopala LC.
    Ann Clin Psychiatry; 2002 Jun 30; 14(2):113-21. PubMed ID: 12238736
    [Abstract] [Full Text] [Related]

  • 6. Does early antipsychotic response predict long-term treatment outcome?
    Rasmussen SA, Rosebush PI, Mazurek MF.
    Hum Psychopharmacol; 2017 Nov 30; 32(6):. PubMed ID: 28952166
    [Abstract] [Full Text] [Related]

  • 7. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB.
    Am J Psychiatry; 1997 Jun 30; 154(6):782-91. PubMed ID: 9167505
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.
    Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA.
    J Clin Psychopharmacol; 2019 Jun 30; 39(4):336-343. PubMed ID: 31205194
    [Abstract] [Full Text] [Related]

  • 9. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B.
    J Clin Psychiatry; 1995 Mar 30; 56(3):94-100. PubMed ID: 7883736
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD.
    Am J Psychiatry; 1999 Jan 30; 156(1):79-87. PubMed ID: 9892301
    [Abstract] [Full Text] [Related]

  • 11. Buspirone in the treatment of tardive dyskinesia.
    Moss LE, Neppe VM, Drevets WC.
    J Clin Psychopharmacol; 1993 Jun 30; 13(3):204-9. PubMed ID: 8102622
    [Abstract] [Full Text] [Related]

  • 12. Risperidone in treatment-refractory schizophrenia.
    Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC.
    Am J Psychiatry; 1999 Sep 30; 156(9):1374-9. PubMed ID: 10484947
    [Abstract] [Full Text] [Related]

  • 13. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S, Sandmann U, Genz A.
    Pharmacopsychiatry; 2005 Jul 30; 38(4):171-7. PubMed ID: 16025420
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN, Matroos GE, Hoek HW, Kahn RS.
    Schizophr Res; 1996 May 30; 19(2-3):195-203. PubMed ID: 8789918
    [Abstract] [Full Text] [Related]

  • 15. Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
    Carbon M, Kapoor S, Sheridan E, Al-Jadiri A, Azzo S, Sarkaria T, Kane JM, Saito E, Correll CU.
    J Am Acad Child Adolesc Psychiatry; 2015 Sep 30; 54(9):718-727.e3. PubMed ID: 26299293
    [Abstract] [Full Text] [Related]

  • 16. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Sep 30; 59 Suppl 12():23-7. PubMed ID: 9766616
    [Abstract] [Full Text] [Related]

  • 17. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N, Rabinowitz J, Davidson M, Emsley R, Harvey PD, Kopala L, McGorry PD, Van Hove I, Eerdekens M, Swyzen W, De Smedt G, Early Psychosis Global Working Group.
    Am J Psychiatry; 2005 May 30; 162(5):947-53. PubMed ID: 15863797
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC, Hsu MC, Yeh IN, Kuo CC.
    Int J Psychiatry Clin Pract; 2012 Sep 30; 16(3):178-88. PubMed ID: 22404731
    [Abstract] [Full Text] [Related]

  • 19. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST.
    Rybakowski JK, Vansteelandt K, Remlinger-Molenda A, Fleischhacker WW, Kahn RS, Peuskens J, EUFEST Study Group.
    Eur Neuropsychopharmacol; 2014 Sep 30; 24(9):1500-5. PubMed ID: 25085534
    [Abstract] [Full Text] [Related]

  • 20. Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales.
    Widschwendter CG, Karayal ON, Kolluri S, Vanderburg D, Kemmler G, Fleischhacker WW.
    Int J Neuropsychopharmacol; 2015 Jun 26; 18(12):. PubMed ID: 26116494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.